Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?

被引：0
|
作者：
Pierre Vera
Matthieu John Ouvrier
Sébastien Hapdey
Marc Thillays
Anne Sophie Pesquet
Brigitte Diologent
Françoise Callonec
Anne Hitzel
Agathe Edet-Sanson
Jean François Ménard
Fabrice Jardin
Hervé Tilly
机构：
[1] Henri Becquerel Centre and Rouen University Hospital,Department of Nuclear Medicine
[2] University of Rouen,QUANT.I.F
[3] Henri Becquerel Centre, LITIS [EA (Equipe d’Accueil) 4108], Faculty of Medicine
[4] Henri Becquerel Centre,Department of Clinical Research
[5] Rouen University Hospital,Department of Radiology
[6] Henri Becquerel Centre,Department of Biostatistics
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷
关键词：
PET/CT; Contrast-enhanced CT; Lymphoma; Chemotherapy; FDG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1943 / 1952
页数：9
相关论文
共 50 条
  • [41] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Christopher C. Riedl
    Katja Pinker
    Gary A. Ulaner
    Leonard T. Ong
    Pascal Baltzer
    Maxine S. Jochelson
    Heather L. McArthur
    Mithat Gönen
    Maura Dickler
    Wolfgang A. Weber
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1428 - 1437
  • [42] Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients
    En-Tao Liu
    Tao-Tao Sun
    Hao-Jian Dong
    Si-Yun Wang
    Ze-Rui Chen
    Chao Liu
    Dan Shao
    Zhou-Yang Lian
    Qiu Xie
    Shu-Xia Wang
    EJNMMI Research, 10
  • [43] Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed?
    Kuhn, Felix P.
    Huellner, Martin
    Mader, Caecilia E.
    Kastrinidis, Nikos
    Huber, Gerhard F.
    von Schulthess, Gustav K.
    Kollias, Spyros
    Veit-Haibach, Patrick
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (04) : 551 - 558
  • [44] Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Yasushi Kaji
    Ichio Fukasawa
    Noriyuki Inaba
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1912 - 1920
  • [45] Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
    Elstrom, R. L.
    Leonard, J. P.
    Coleman, M.
    Brown, R. K. J.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1770 - 1773
  • [46] Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Kaji, Yasushi
    Fukasawa, Ichio
    Inaba, Noriyuki
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1912 - 1920
  • [47] Can Full-Dose Contrast-Enhanced CT Be Omitted From an FDG-PET/CT Staging Examination in Newly Diagnosed FDG-Avid Lymphoma?
    van Hamersvelt, Hanneke P.
    Kwee, Thomas C.
    Fijnheer, Rob
    Beek, Frederik J. A.
    de Klerk, John M. H.
    Nievelstein, Rutger A. J.
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2014, 38 (04) : 620 - 625
  • [48] FDG-PET Dynamic Contrast-Enhanced CT in the Management of Breast Cancer
    Das, Chandan J.
    Al-Mullah, Abeer
    Kumar, Rakesh
    PET CLINICS, 2009, 4 (03) : 255 - 263
  • [49] Quantitative contrast-enhanced CT attenuation evaluation of osseous metastases following chemotherapy
    Chang, Connie Y.
    Simeone, F. Joseph
    Torriani, Martin
    Bredella, Miriam A.
    SKELETAL RADIOLOGY, 2017, 46 (10) : 1385 - 1395
  • [50] Quantitative contrast-enhanced CT attenuation evaluation of osseous metastases following chemotherapy
    Connie Y. Chang
    F. Joseph Simeone
    Martin Torriani
    Miriam A. Bredella
    Skeletal Radiology, 2017, 46 : 1385 - 1395
12345